When Should You Start Botox?
When Should You Start Botox?
The question arrives in my consultation room in two forms, and they are usually the same person at different ages.
The first version comes from someone in her late twenties. She has no real lines yet. She has been told — by an aesthetician, by an algorithm, by a friend who started last year — that the smart move is to begin now, before anything forms. She wants to know if she’s already behind.
The second version comes from someone in her late forties. She has lines she doesn’t love. She wants to know if she has missed the window. Whether starting now is worth it, or whether she should have done this fifteen years ago.
Both of them are asking a question the industry has answered badly, because the industry has a financial interest in one answer: start early, stay consistent, never stop. That answer is good for revenue. It is not always good medicine.
Here is the honest version.
“Preventative Botox” is a real concept, not a marketing invention
Let’s be precise, because the term gets used loosely.
Neuromodulators relax the muscles that create dynamic wrinkles — the lines that appear when you make an expression. Over years, repeated folding of the skin along those same lines contributes to static wrinkles: the lines that remain visible even when your face is at rest.
The logic of preventative treatment is that if you reduce the muscle activity before deep static lines have etched in, you slow the rate at which those static lines form. There is reasonable clinical basis for this. It is not a fabrication.
But “there is a basis for it” is not the same as “everyone should do it at the same age.” The concept is real. The blanket recommendation built on top of it is where the medicine gets sloppy.
Why there is no universal starting age
Muscle strength and movement patterns. Some people have a naturally strong, hyperactive glabellar complex — the muscles between the brows — and will etch a deep “11” line by their early thirties. Others have softer movement patterns and minimal etching well into their forties. The first person may genuinely benefit from earlier intervention. The second person treating at the same age is treating a line that wasn’t going to be a problem for another decade.
Skin quality and genetics. Collagen density, skin thickness, and how your skin ages are substantially genetic. Two people the same age with the same sun history can have very different rates of static line formation. One person’s preventative window opens years before the other’s.
Sun exposure and lifestyle history. The single largest external driver of skin aging is ultraviolet exposure. A patient with significant cumulative sun damage is on a different timeline than one who has been disciplined about photoprotection her whole life.
Where the lines actually are. Preventative logic applies more cleanly to some areas than others. The glabella and forehead respond to the dynamic-to-static argument fairly well. Other areas of the face age primarily through volume loss and structural change, not repeated muscle folding — and no amount of early neuromodulator addresses those.
A responsible answer to “when should I start” requires someone to actually look at your face, your movement, and your skin. Anyone who gives you an age before they’ve done that is quoting a script.
The case against starting too early
There is a real downside to beginning preventative treatment before there is anything to prevent, and it rarely gets discussed.
Muscle changes over time. Long-term, consistent relaxation of a muscle leads to some degree of atrophy — the muscle weakens and thins with disuse. In the right context, that’s part of the intended effect. But a patient who begins aggressive treatment of a muscle that was never going to be a problem can, over many years, alter the architecture of her face in ways that weren’t necessary and aren’t always desirable. The forehead that has been fully frozen since age 26 is a different forehead at 45 than it would have been.
It commits you to a maintenance relationship you didn’t need yet. Neuromodulator results last roughly three to four months. Starting early means starting a recurring commitment — financial and logistical — years before there was a clinical reason to. That’s not a medical problem. But patients should make that decision with clear eyes, not because they were told they were “already behind” at 27.
It can mask the actual question. A 28-year-old worried about aging often does not need a neuromodulator. She needs sun protection, a sound skincare foundation, and good information. Selling her Botox instead of telling her that is the easier transaction. It is not the better care.
The case against thinking you’ve missed the window
The flip side is just as common, and just as wrong.
The patient in her late forties who believes she’s too late is operating on a misunderstanding of what neuromodulators do at her stage. The goal at her age is not prevention — that ship has reasonably sailed for some lines. The goal is management: softening the dynamic component of lines that already exist, slowing further deepening, and being one part of a broader plan that also addresses volume and skin quality.
There is no point at which neuromodulator treatment stops being useful. There is only a point at which it stops being the whole answer and becomes one part of the answer. A patient starting at 48 has not missed anything. She has simply arrived at a stage where the plan involves more than one tool.
The “missed the window” anxiety is, in its own way, the same problem as the “already behind” anxiety. Both come from thinking about Botox as a race against a clock, rather than as a clinical decision made in the context of a specific face at a specific time.
What I actually tell patients
When someone asks me when she should start, the conversation goes roughly like this.
If she’s in her twenties with no meaningful etching: usually, not yet. I’ll look at her movement and tell her honestly whether she has the kind of strong, etching musculature that might justify earlier intervention, or whether she has years before this is a real question. If it’s the latter, I tell her so, and we talk about photoprotection and skin foundation instead. She is often surprised that a clinic told her to wait. That surprise tells me how rarely it happens.
If she’s in her thirties with early static lines beginning to set: this is frequently where the preventative argument is genuinely strongest. The dynamic component is treatable, the static lines aren’t yet deep, and intervention here can meaningfully slow the trajectory. For many faces, this is the real window — not the twenties.
If she’s in her forties or beyond: we talk about neuromodulators as one component of a plan, not the whole plan. What the toxin can do, what it can’t, and what else her face is asking for that a neuromodulator doesn’t address.
In every case, the starting point is the same: I look at her face first. The age is an output of that assessment, not an input to it.
What to ask before you start
Two questions, whatever your age.
First: Will you tell me if you think I should wait?
A clinic that is assessing you will sometimes tell you that you don’t need treatment yet. A clinic that is selling you a service will almost never say that. The willingness to tell a patient “not yet” is one of the clearest signals of which kind of clinic you’re in.
Second: What are you basing the recommendation on — my face, or my age?
The answer should be specific to you. Your muscle movement, your skin, your line formation, your history. If the recommendation is essentially “people your age usually start now,” you are being given a script, not an assessment.
The actual answer
The honest answer to “when should I start Botox” is that there is no answer until someone has looked at you.
For some people, the right time is their early thirties. For some, it is later. For a meaningful number of people in their twenties being told they’re already behind, the right answer is: not yet, and the fact that someone told you otherwise says more about their business model than your face.
Aesthetic medicine done well is not a clock you are losing a race against. It is a series of specific decisions, made for a specific face, at the points in time when they actually make sense. The starting line is wherever the assessment says it is — and a good clinician will tell you the truth about where that is, even when the truth is “come back in five years.”
Sonia Vilos is a Nurse Practitioner and the founder of bespøke by SkinAlchemy, a medical aesthetics clinic in London, Ontario. She trained in facial anatomy and injection technique under Dr. Sebastian Cotofana, Dr. Arthur Swift, Dr. Thuy Doan, and Julie Horne across programs in four countries. She is the supervising Medical Director to independent nurse injectors across Ontario. Complimentary consultations are available at skinalchemy.janeapp.com.
